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Abstract.  The ability of SV40 T antigen to cause ab- 
normalities in cartilage development in transgenic 
mice and chimeras has been tested. The cis-regulatory 
elements of the COL2A1 gene were used to target ex- 
pression of SV40 T antigen to differentiating chondro- 
cytes in transgenic mice and chimeras derived from 
embryonal stem (ES) cells bearing the same transgene. 
The major phenotypic consequences of transgenic 
(pAL21) expression are malformed skeleton, dis- 
proportionate dwarfism, and perinatal/neonatal death. 
Expression of T antigen was tissue specific and in the 
main characteristic of the mouse od(ID collagen gene. 
Chondrocyte densities and levels of ot I(ID collagen 
mRNAs were reduced in the transgenic mice. Islands 
of cells which express cartilage characteristic genes 
such as type fib procollagen, long form or(IX) colla- 
gen, o~2(XI) collagen, and aggrecan were found in the 
articular and growth cartilages of pAL21 chimeric fe- 
tuses and neonates. But these cells, which were ex- 
pressing T antigen, were not properly organized into 
columns of proliferating chondrocytes. Levels of od0l) 
collagen mRNA were reduced in these chondroeytes. 
In addition, these cells did not express type X colla- 
gen, a marker for hypertrophic chondroeytes. The 
skeletal abnormality in pAL21  mice may therefore be 
due to a retardation of chondrocyte maturation or an 
impaired ability of chondroeytes to complete terminal 
differentiation and an associated paucity of some carti- 
lage matrix components. 
URING vertebrate development,  the establishment  of 
a cartilage  template involves the orderly differen- 
tiation of  chondrocytes. This is important as the tem- 
plate forms a temporary framework for the formation of en- 
dochondral bone (Horton, 1993). Cartilage also is important 
because it has to withstand high cyclical loads and absorb 
shocks. This is achieved by the synthesis of a complex ex- 
tracellular matrix,  consisting  of hyaluronate-proteoglycan 
complexes (Rosenberg and Buckwalter,  1986) and at least 
five different collagens, type II, VI, IX, X, and XI (Mayne 
and Irwin, 1986), one of the major components of which is 
type II collagen.  There is growing evidence that mutations 
in the human oil(l/)  collagen gene (COL2A1)  ~ can cause 
some inherited chondrodysplasias,  disorders which result 
in skeletal abnormalities  characterized by disproportionate 
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1. Abbreviatious used in this paper: COL2A1, oil(H) collagen gene; d.p.c., 
days post coitum; ES, embryonal stem cells; Tag, SV40 T antigen. 
dwarfism  (Spranger  and  Maroteaux,  1990; Horton  and 
Hecht, 1993). Mutations in COL2A1 have been implicated 
in Stickler syndrome  (Francomano et al, 1987; Ahmad et al., 
1991, 1993; Brown et al., 1992;; W'mterpacht et al., 1993), 
Kniest  dysplasia  (Winterpacht  et al.,  1993; Poole  et al., 
1988), lethal (Langer-Saldino) aehondrogenesis  (Vissing et 
al., 1989), spondyloepiphyseal dysplasia (Lee et al., 1989; 
Tiller et al., 1990; Cole et al., 1993; Vikkttla et al., 1993a), 
Goldblatt syndrome (Bonaventure et al.,  1992), hypochon- 
drogenesis (Horton et al., 1992), and also in primary gener- 
alized  osteoarthfitis  (Palotie  et al.,  1989; Vikkula  et al., 
1993b;  Knowlton  et al.,  1990; Ala-Kokko et al.,  1990). 
Dominant negative mutations in the ~ 1(I1) collagen gene ex- 
pressed in transgenic mice result in severe chondrodysplasia 
(Mets~ranta et al., 1992; Garofalo et al., 1991; Vandenberg 
et al., 1991). These studies confirm the association of muta- 
tions in COL2A1 with some forms of  human ehondrodyspla- 
sia.  However, over 150 different ehondrodysplastic  condi- 
tions have been described in humans varying from being 
perinatal lethal,  to deforming during life, to being so mild 
that they are difficult to detect (Spranger and Maroteaux, 
1990; Horton and Hecht, 1993). The molecular bases un- 
derlying these disorders are largely unknown. 
SV40 T antigen (Tag) is the major multifuncfional regula- 
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effects on eukaryotic cells (Stahl and Knippers,  1987; Butel 
and Jarvis, 1986; Fanning and Knippers,  1992). Expression 
of Tag  in  transgenic  mice  also  promotes  tumorigenesis 
(Hanahan,  1988;  Adams and Cory,  1991).  Tag has been 
found to stimulate cell  proliferation by accelerating  the cell 
cycle and inducing DNA synthesis.  Transformation of some 
types of cells by Tag is also known to result in downregula- 
tion  of  the expression  of  some extracellular  matrix compo- 
nents  for  example collagenase  (Imai  and Takano, 1992) and 
type I collagen (Bornstcin  and Sage, 1989; Parker et al., 
1992). The differentiated  phenotype of cultured  chondro- 
cytcs  has been shown to  be sensitive  to  viral  transformation 
and  the  expression  of  Tag or  other  oncogenes, which can re- 
sult  in  varying  degrees  of  dedifferentiation  and  a decrease  in 
type II collagen  synthesis  (Adams et al.,  1982; Bcnya and 
Brown, 1986; Thenet et al., 1992; Horton ctal., 1988). 
However recently,  Tag has been shown to induce chondro- 
cyte  proliferation  without loss  of the differentiated  pheno- 
type (Mallein-Gerin and Olsen, 1993). 
Apart from mutations in  cartilage  matrix genes which re- 
sult  in  a structurally  defective  extracellular  matrix,  it  is  pos- 
sible  that  inappropriate  control  of chondrocyte differentia- 
tion  can cause abnormal skeletogenesis  brought about by a 
perturbation  of  cartilage  development. Alternatively,  chon- 
drodysplasia  could  arise  from  a  perturbation  of  levels  or  tim- 
ing  of  expression  of  extracellular  matrix components of  car- 
tilage  and bone. To investigate  these  possibilities,  based on 
the ability of Tag to alter the proliferative/differentiated state 
of cultured chondrocytes,  we have used Tag as a tool to inter- 
fere  with  skeletogenesis  by  targeting  Tag  expression  to 
differentiating chondrocytes  in transgenic  mice. 
DNA sequences sufficient to direct tissue specific expres- 
sion of the human COI.2A1  gene in mice have been previ- 
ously identified (Lovell-Badge  et al.,  1987b) and cell trans- 
fection studies have shown that the first intron of the rat al(II) 
collagen gene contains a chondrocyte  specific enhancer ele- 
ment (Horton et al., 1987). Since the first introns of the rat 
and human od(I~ collagen genes show high degree of conser- 
vation (Ryan et al., 1990), it was likely that the human intron 
sequences also contain a similar cartilage specific enhancer 
element. We therefore constructed a chimeric  plasmid con- 
taining 4.5 kb of 5' flanking DNA and 1.8 kb from the first 
intron of the human COL2A1  gene linked to the Tag gene 
and introduced this construct  (pAL21,  see Fig.  1) into the 
mouse germline by transgenesis.  This paper reports that the 
phenotypic consequence of carrying this COL2A1-Tag trans- 
gene is major skeletal malformation, disproportionate dwarf- 
ism, and perinatal death in the transgenic mice. Expression 
of Tag was tissue specific  and we also show that the likely 
cause of the skeletal abnormality may be an impaired ability 
of chondrocytes  to differentiate properly. 
Materials and Methods 
Generation and Identification of Tmnsgenic 
and Chimeric Mice 
Two plasmids were used to generate lransgenic mice (see Fig.  1 [Cheah et 
al., 1985]). DNA inserts of plasmids pAL21 and pAA2 were released using 
KpnI and NotI and NotI alone, respectively (Fig. 1), and microinjected into 
the pronuclei  of one cell embryos  from F1  hybrid  mice (C57BL/6  × 
CBA/N). Transgenic mice were identified by PCR, Southern blot or dot blot 
analyses of genomic DNA prepared from the tails of embryos or recently 
weaned mice.  Identification of pAL21 transgenic mice by PCR was per- 
formed using nested ollgenucleotide primers to the early region of the Tag 
gene (GenBank accession No. J02400) as follows: primer 1, 5'-TCAGC~- 
GGAGGTGTGGGAGG-3' (nt 2704-2723);  primer 2, 5'-~.C~,3G- 
A~GTCCA-3'  (complementary to nt 3371-3390); primer 3, 5'-GAG- 
CC~TGTGAATC-3'  (nt 2808-2828) and primer 4, 5'-CCTAAA- 
ACACTGCAGGCCAG-3' (complementary  to  nt 3198-3217).  PCR am- 
plifications were for a first round of 20 cycles of denaturation at 94°C 0.1 
min, annealing 65°C, 0.5 min and synthesis (2.5 U Taq polymerase, Ceres 
Corp.),  72°C 0.5 win usin  8 primers  1 and 2, followed by a second round 
of 20 cycles using 1 ~tl from the first reaction and primers 3 and 4. The trans- 
genic identities of pAL21 mice were confirmed by Southern hybridizations 
of BamHI digested genomic DNAs using a 2.7-kb BamHI fragment from 
pAL21 as a probe, pAA2 mice were identified by the PCR using the follow- 
ing oligonucleotide primers  for the E.  coli lacZ gene:5'-CGTAATAGC- 
GAAGAGC~CCG-3';  5'-TCCAAC~CCATCACC-3'  (nt  112-130, 
and complementary  to nt 558-577, respectively; translation  start  ffi 1). 
DNA insert from pAL21 (25 ~tg) and 250 ng of BamHI linearised plas- 
mid carrying the neomycin resistance geue, (pGKneo, gift of R, Krumlauf, 
National Institute for Medical Research,  London,  UK) was incorporated 
into the genome of CCE embryonal stem (ES) cells (gift of E. Robertson, 
Harvard  University) by electroporation  at  160 V, 960/tF using a Gene 
Pulser apparatus (BinRad Labs., Hercules, CA). After growth in medium 
(l~bertson, 1987) containing 0.4 mg/ml C,418, resistant ES colonies were 
selected, and the presence of Tag transgene was confirmed by Southern blot 
analysis. Mouse chimeras were generated by injecting cells from a CCE line 
carrying four copies of pAL21 into C57BI/6J blastocysts (Bradley, 1987). 
Chimerism was determined on the basis of agonti pigmentation in the coat 
and by determination  of copy number of pAL21 in somatic tissues. 
RNA Probes, RNA Analyses, 
and In Situ Hybridization 
Riboprobe for the detection of mouse ~10I) collagen mRNAs in RNase pro- 
tection  assays were  transcribed  in  vitro  using  plasmid  pELlll  which 
contains exon 1 as described previously (Cheah et al., 1991). Probes for 
Col2a-1 mRNAs used for in situ hybridization were pSOK10, contalnin~ the 
alternatively spliced exon 2 characteristic of type ILA procollagen mRNA 
and pELIll (Cheah et al., 1991; Ng et al.,  1993). "Ihg mRNAs were de- 
tectnd by  RNase protection  assays using  a  riboprobe  transcribed  from 
pKC32 (Fig.  1 [Haushan,  1985]). 
od(IX) short form and long form collagen (Mura~i et al., 1990) probes, 
pNJ59 and pNJ60 respectively, were made by RNA-PCR. Single-stranded 
eDNA was transcribed from 40 ~g of 17.5-d fetal total RNA by AMV re- 
verse transcriptase  (35 U, Seikagaku America Inc., Rockville, MD) using 
a primer complementary  to exon 8 of the mouse al(IX) collagen gene 
(5'-CC~_CTC~-3')  in 0.05 M Tris-HCl,  pH &3, 75 mM 
KC1, 3 mM MgCI2, 125/~M each of dATP, dCTP, dGTP, and dTTP at 
42°C for 30 min. This eDNA was used as template for generating pNJ59 
and pNJ60 by the PCR. pNJ59 was made using oligonucleofide primers 
complementary to exon 1" of mouse od(IX) collagen gene (5'-ATGGCC- 
~CTGGC~-3',  as 5' primer and 5'-TTGAFJC~GCACACAA- 
GCGGA-3',  as  3' primer),  pNJ60  was  made  using  an oligenucleotide 
primer corresponding to exon 4 ([5'-GTAGACTICAGGATTCCA-3'] as 5' 
primer)  and exon 6 (5'-AGCATCCACTGGAGTTCAAA-3')  as 3' primer. 
The PCR was carried out in buffer containin~  10 mM Tris-HCl,  pH 8.3, 
50 mM KCI, 1.5 mM MgCI2, 375/tM each of dATP, dCTP, dGTP, dTTP, 
50-ng primers, and 5 U Taq polymerase (Perkin-Elmer Cetus Corp., Nor- 
walk, CT) as follows: 1 min denaturation of DNA, 94eC;  1 min anlg~lin~ 
reaction,  65°C; 2 rain extension reaction,  72°C for 30 cycles. Both the 
RNA-PCR products were cloned in pGEM7-Zf(+)  (Promege Corp., Madi- 
son, WI). 
The ot2(XI) collagen probe  was pVLm3B1 which contained  a 900-bp 
BamHI fragment encoding part of the C-propeptide  of the mouse ¢2(X1) 
collagen gene (Lui, C.-Y., L. J. Ng, and K. S. E. Cheah, manuscript in prep- 
aration) subcloned in pUBS (gift from G.  Murphy, John Innes Institute, 
Norwich,  UK).  pNJ62  contained  a  800-bp  Kpnl-BamHI  frasment  of 
mouse aggrecan eDNA (generous ~  from Y. Yamnda, National Institute 
of Dental ~h,  Bethesda,  MD) subcloned in pGEM7-Zf(+). Mouse 
type X collagen probe was pRK26, encoding part of the COOH-terminal 
noncollagenous domain  and  3' untranslated  region (Kong et al.,  1993). 
Mouse od(I) collagen probe contained  exon 2 of the gene (Cheah et al., 
1991). 
Total RNA  was prepased from heads, limbs, or ribs  of  embryos by the 
lithium  chloride-urea method (Lovell-Badge, 1987). RNase protection  as- 
says  and in situ  hybridization  were carried  out as described (Cheah et al., 
1991). 
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Ctyostat sections (7/an) fixed in acetone were immunostained using a 
mouse monoclonal  antibody (ID9) specific  for SV40 large T antigen (gift 
of  David Lane, University  of  Dundee, Scotland)  as described  (Clw~ et al., 
1991). Protein  was extracted  from  mouse  fetal  limbs or neonate  tissues (Fig. 
6,  see legend) and from a Tag expressing monkey epithelial cell line, 
483/SV40 (gift of Beverley  Griffin, Royal Postgraduate Medical School, 
London, UK). Cells/tissues were resuspended in 4% SDS, 20% glycerol, 
125 mM Tris-HCl,  pH 6.8, 1% 2-mercaptoethanol  and disrupted by sonica- 
tion on ice. Samples  were  boiled for  5 rain, cell  debris  removed  by centrifu- 
gation for 10 rain at 10,000 g. Proteins were separated by SDS-PAGE and 
transferred to Hybond C  Super membrane (Amersham Corp., Arlington 
Heights, IL). Membranes were prehybridized for 2 h at 20°C in 5 % nonfat 
dry milk, PBS, 0.3% Tween 20 (PBST), and hybridized with ID9 antibody 
overnight at 4°C in PBST. After washing in PBST, membranes were in- 
cubated for I h with peroxidase-conjngated  second antibody and the hybrid- 
ization signal detected using Amersham's ECL system and Fuji RX film. 
Results 
COL2AI Regulatory Elements in pAL21 Confer 7Issue 
Specificity of Transgene Expression 
The potential of the COL2A1 regulatory elements to direct 
Tag expression with proper tissue specificity was assessed by 
injecting a control construct similar to pAL21 except that 
Tag was replaced by the/acZ gene (pAA2, Fig.  1). The pat- 
tern of expression of/acZ in pAA2 transgenic fetuses ob- 
tained from different injection experiments was monitored at 
9.5,  12.5, and 13.5 d. Fig. 2 shows that in a  12.5-d pAA2 
transgenlc embryo, lacZ staining was detected in sites ex- 
pected for chondrogenic expression of  od(ll) collagen mRNA. 
Low level expression was also seen in brain neuroepithe- 
lium. Similar results were obtained for 13.5-d fetuses (not 
shown). Histological sections of 9.5-d embryos show stain- 
ing in the paraxial mesenchyme which gives rise to the chon- 
drocranlum (data not shown). Strong and specific expression 
in precursors of the cartilaginous primordia of the skeleton 
such as in vertebrae, limbs, and chondrocranium was also 
found between 12.5-18.5 d  in fetuses from a pAA2 trans- 
genic line of mice (data not shown). Expression of pAA2 in 
different transgenic fetuses (not shown, Leung, K. K. H., 
and K. S. E. Cheah, unpublished results) generally corre- 
lates with the pattern of expression of the mouse Col2a-1 
gene in chondrogenic and nervous tissues (Wood et al., 1991; 
Cheah et al., 1991), confirming that Tag expression could be 
targeted  with  proper  tissue  specificity by  the  COL2A1 
regulatory elements in pAL21 mice. 
pAL21 Transgenesis Is Associated with Perinatal 
Lethality and Abnormality, Not Tumorigenesis 
Only  15  pAL21  transgenlc  mice were found among  184 
adults, a low rate of 8 % compared to a 32 % transgenesis rate 
for adults obtained from injections using pAA2  (Table I). 
These  pAL21  transgenic  founders  were  morphologically 
normal and none developed tumors (at 2-3 years of age) be- 
fore death of natural causes. Five founders were sterile and 
two others failed to transmit the transgene. Of the remaining 
8 fertile founders, none of  the transgenic offspring developed 
tumors. Female founder 123 produced a litter of 9 with only 
one transgenic pup which died at 11 d after birth of  unknown 
cause and necropsy revealed no obvious anatomical abnor- 
mality. Founder 123 failed to breed thereafter and died natu- 
rally at 2.3 yr. Male founder 124 transmitted the transgene 
to only one out of  22 offspring. Back-crossing the transgenic 
offspring to founder 124 gave one normal heterozygous male 
and 2 abnormally small mice which were homozygous. The 
abnormal pups were cannibalized shortly afterward, leaving 
no tissues for biochemical or histological analyses. Two ab- 
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Figure 1.  Restriction enzyme 
maps  of  plasmids,  pAL21 
contained 4.5  kb 5' flanking 
DNA sequence  of  the COL2A1 
gene (Cheah et ai., 1985) in- 
cluding the TATA box linked 
to an XbaI-BamHI  fragment 
from  RIP1-Tag (gift  of  D. 
Hanahan;  [I-Ianahan, 1985]) 
containing the Tag gene (in- 
cinding  the  transcriptional 
start  site)  and  a  1.8-kb 
KpnI-BamHI fragment which 
contains  part  of the first in- 
tron.  pAA2 contained  the 
same COL2A1 sequences in 
pAL21 linked to the E.  coli 
lacZ gene. pKC32 contained a 
476-bp BstXI-XbaI fragment 
from  the 5' end ofthe Tag gene 
yielding a  specific 254  base 
protected fragment in RNase 
protection  assays. Hatched 
box, COL2A1 5' flanking se- 
quences;  cross-hatched box, 
COL2A1  first  intron  se- 
quences; solid box, Tag gene; 
lined box, lacZ gene. 
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ral tissues of a 12.5-d pAA2 transgenic fetus, reflecting the expres- 
sion pattern  of the  endogenous  Col2a-I  gene.  pAA2  specimens 
were fixed in 4% paraformaldehyde for 15-30 rain and stained in 
X-gat reagent overnight and cleared in glycerine for microscopic 
examination.  Approximately 17 % of pAA2 transgenic fetuses ex- 
pressed the transgene.  Bar, 0.5 ram. 
normally small mice were produced from the heterozygous 
offspring of mouse 124 and both died of  unknown cause near 
to weaning age. Cannibalization  of these mice precluded au- 
topsy. 
To determine if the low incidence  of pAL21  transgenic 
mice at weaning age reflected cannibalization  at birth and/or 
lethality  in utero,  the transgenesis  rate and litter sizes were 
determined at different  stages of gestation between 10.5 to 
18.5 days post coitum (d.p.c.).  The pAL21 transgenesis  rate 
Table L Litter Sizes and Transgenesis Frequencies of 
pAL21 and pAA2 Mice 
Litter size per 30 
embryos transferred (n) 
No. of transgenic/No, of 
animals (%)* 
Age 
(d.p.c.).  pAL21  pAA2  pAL21  pAA2 
10.5  21  (2)  6.4(2)  9/16  (56)  0/10  (0) 
11.5  12.5 (2)  nat  5/13  (39)  4/9  (44) 
12.5  14.0 (6)  7.2 (17)  10/64  (16)  32/119 (27) 
13.5  12.3  (3)  9.4 (4)  11/25  (44)  6/27  (22) 
14.5  11.1  (13)  nat  22/117(19)  5/9  (56) 
15.5  12.5  (3)  ND  20/47  (43)  ND 
16.5  9.9 (8)  ND  20/46  (44)  ND 
17.5  9.2 (6)  nat  9•28  (32)  4/9  (45) 
18.5  10.4 (22)  na~  61/125  (49)  0/1  (0) 
19.5foirth  9.6 (47)  10  (10)  47/272 (17)  75/120 (63) 
Weaning  5.9 (32)  10.9 (11)  15/184 (8)  50/157 (32) 
Fetuses were harvested at various time points. To take into account the varia- 
tions in embryo transfer between experiments and to allow inter-litter compari- 
son, liner sizes wre normalized on a per 30 embryo-transferred basis. 
* Overall incidence  of mmsgenesis for fetal stages: pAL21 = 38.2%; pAA2 = 
41.4%. 
t na, single observation, therefore not analyzed. ND, not determined; n, num- 
ber of fitters analyzed, d.p.c., days post eoitum. 
was  higher  for  fetuses  (overall  38%)  than  for  newborns 
(17%), but the litter size remained  relatively  constant up to 
18.5 d.p.c.  (Table I). There was a high incidence  of abnor- 
mality and/or stillbirth  (37%) in newborn litters  obtained 
from pAL21 injections and the majority (75 %) of the abnor- 
mal newborns were transgenic.  The results suggested  that 
pAL21 transgenic  mice were probably being lost during the 
perinatal  period.  There was a further loss of pAL21  pups 
during suckling, resulting in a significant drop in transgenic 
frequency at weaning age. 
Overall 78 (36%) pAL21 transgenic  fetuses between 10.5 
and 18.5 d were found to display morphological defects com- 
pared to a 9 % incidence of abnormality among their non- 
transgenic littermates. Abnormalities  associated with pAL21 
transgenesis  were first identified in 20% of  the 11.5-d fetuses 
and the frequency of recognizable  defects increased  steadily 
to 44.3% at 18.5 d. 
To test if the neonatal  lethality  and abnormality was as- 
sociated with the Tag transgene  or was caused by competi- 
tion between the COL2A1  sequences and  the endogenous 
Col2a-1 promoter for transcription  factors, a comparison of 
transgenesis  rates was made for injections using pAA2. The 
transgenesis  frequencies and litter size at birth for pAA2 fe- 
tuses were similar to that of pAL21 up to 19.5 d.p.c.  (Table 
I). A significantly higher transgenic frequency was found for 
pAA2 at birth and at weaning, and few pups died at birth or 
showed developmental  retardation.  Only 1 out of 51 pAA2 
embryos and 2 out of 113 nontransgenic  littermates  at fetal 
stages displayed developmental  retardation  (small size) and 
the frequency  of abnormality  and lethality  for transgenic 
pAA2 animals  at  birth  was  also  low (11%).  Overall,  for  ex- 
periments  using  pAA2, 9  % of  transgenic  animals  and  6  % of 
nontransgenic  littermates  were  abnormal. 
The Major Abnormality in pAL21 Transgenic Mice Is 
Skeletal Malformation 
Characteristic  abnormalities  in transgenlc  pAL21 newborn 
mice were foreshortened limbs with stumpy digits, flattened 
faces, abnormal neck and shoulder posture, short trunk, sub- 
cutaneous edema, and lethargic movement (Fig. 3). Alizarin 
red-alcian blue staining  of skeletons (Fig.  4 A-C [Kessel 
and Gruss,  1991]) showed  (a) retarded ossification  of the 
craniofacial  skeleton,  (b)  inappropriate  sizes  of skeletal 
components,  (c) poorly developed cervical vertebrae result- 
ing in hyperextension and shortening of  the neck, and (d) the 
lack of chondrification,  exemplified by the reduced alcian 
blue-stained matrix in otic capsules and laryngeal  skeleton, 
and in an extreme case, the absence of frontonasal  cartilage. 
The  types of abnormality  associated  with  pAL21  and 
pAA2 fetuses are shown in Table I1. Among the various types 
of defects present in the pAL21  fetuses,  smaller  body size 
and foreshortened  limbs were the most frequently encoun- 
tered. There was also a specific predominance of defects of 
the craniofacial,  axial,  and appendicular  skeleton, and the 
brain  in  pAL21  fetuses.  Skeletal  abnormalities  included 
shortening  and/or hyperextension  of the neck (11% of the 
transgenic  pAL21  fetuses),  reduction  of limb  (22%)  and 
digit lengths (7%), and reduced head size and snout length 
(10%).  Approximately  35%  (24/69)  of abnormal  pAL21 
transgenic  fetuses  displayed  multiple  skeletal  defects.  The 
frequency of multiple skeletal defects in abnormal nontrans- 
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mice. To minimize loss of neonates due to can- 
nibalization at or just after birth,  pups were 
born in rat cages so that they would fall through 
the larger mesh openings on delivery. (,4 and 
C) Nontransgenic pups, (B) transgenic litter- 
mate of A showing reduced trunk length (tr), 
foreshortened forelimb (fl), poor digit devel- 
opment, shortened neck (nk) and snout (sn), 
and (D) the partially cannibalized transgenic 
littermate of C showing stumpy forelimbs (fl), 
scaphoid and laterally compressed head (hd), 
and flattened face (fn). Bar, 5 nun. 
genic animals from pAL21 injections was 7.4%  (2/27) and 
none were observed for pAA2.  Morphometric analyses of 
pAL21  transgenic  fetuses  at  15.5  and  18.5  d  revealed a 
progressive reduction of head size and limb length and also 
a preferential reduction in the length of distal limb segments 
(Table  HI).  Histological  examination  of the  craniofacial 
structures revealed the poor differentiation of nasal septum, 
deformed and foreshortened cartilage of the base of the neu- 
rocranium. This deficiency in the midline chondrogenic tis- 
sues  resulted  in  the  medial  and  ventral  displacement  of 
craniofacial structures such as the inner ear, jaws, and nasal 
cavities (Fig. 5). However cleft palate was not observed. 
Retarded brain development was observed in some trans- 
genic fetuses (18 %). There was poor differentiation of neu- 
ronal layers of  the brain, disproportionate growth of  the mid- 
brain and forebrain, retarded development and inadequate 
foliation of the cerebellum, and a general reduction of brain 
size,  which may be secondary to poor skull  development 
(Fig. 5). 
Tissue Pattern of  Expression of Tag in pALM Mice Is 
Characteristic of ~  II Collagen 
The tissue pattern of expression of the COL2A1-Tag  trans- 
gene was assessed in fetuses between 12.5 d and 18.5 d and 
in newborns using RNase protection assays, Western analy- 
ses  and  immunohistochemistry.  RNase  protection  assays 
yielded protected fragments of  expected size, suggesting cor- 
Cheah et al. Chordlrodysplasia in COL2AI-SV40  T Antigen Transgenic Mice  227 Figure 4.  Alizarin-alcian  blue skeletal preparations of (.4) normal and (B and C) abnormal transgenic pAL21 newborn. Newborn mice 
were eviscerated and the skeletons were stained with alizarin red S and alcian blue (Kessel and Gruss, 1991). The transganic pups display 
hyperextended neck due to the thinner posterior arches (pa) of cervical vertebrae and the congested intervertebral space. Chondrification 
is diminished in the sutural bone such as the temporal and supra-occipital components of the skull (sk), and in the larynx and trachea 
(arrow). The orbital cavity is oversized, but mandible and maxilla (jw) are underdeveloped. Pup (C) in addition shows a severely deficient 
frontonasal cartilage (fn). Bar, 5 nun. 
rect  initiation  of transcription.  Tag-specific antibody  de- 
tected a 97-kD polypeptide expected for Tag in Western anal- 
yses,  indicating  that  the  transgene  mRNA  was  properly 
translated (Fig. 6). Not all transgenic animals expressed Tag 
but a  significant proportion did. Including fetuses and new- 
borns, the total number where Tag mRNA could be detected 
was 22  animals out of 59 tested.  Of 26 pAL21  transgenic 
Table II.  Incidence of Defects Observed in pAA2 
and pAI21  Fetuses 
pAA2 
Frequency 
(% of  all  fetuses)* 
pAL21 
Phanotype  biT  T  biT  T (% incidence)~ 
Resorbed/dead  ND  ND  0.3  10.8 (21.7) 
Small size  5.8  9.4  4.4  13.5 (27.2) 
Short limb  0  0  2.0  13.5 (21.7) 
Short snout/small  head  0  0  0.3  9.9 (20.0) 
Short/hyperextended  neck  0  0  0  5.4 (10.9) 
Deformed or shortened skull base  0  0  0  0.9 (1.8) 
Short trunk  0  0  0.6  1.8 (3.6) 
Poor digit formation  0  0  0.6  7.2 (14.5) 
Poor cartilage differentiation  0  0  0  3.6 (7.3) 
Deformed brain  0  0  0  1.8 (3.6) 
Retarded brain development  0  0  0  9.0 (18.2) 
Fetuses  from  pAL21 and pAA2  experiments  collected  at various  times  of gesta- 
tion (Table  I) were first examined  macroscopically  for morphological  assess- 
ment and processed  histologically  for determination  of tissue abnormalities. 
* Overall incidence of  abnormal transgenic fetuses: pAL21  =  36.4% 
(78/214); pAA2 = 6.3% (8/126). 
* Incidence of defect type  in pAL21 transganic  fetuses. 
ArT, non-transgenic. 
T, transgenic. 
ND, not determined. 
newborns tested, Tag expression was detected by both West- 
ern analysis and RNase protection assays in 10, of which 8 
displayed abnormalities such as reduction in limb length and 
short snouts. A representative selection of analyses is shown 
in Fig. 6. 
Immunohistology performed on 44 pAL21 transge~ic fe- 
tuses revealed specific localization of Tag in chondrocytes in 
48 % of abnormal animals (Fig. 7 A), and, in some of these, 
a low level expression in neural tissues (data not shown). Tag 
expression was also detected by RNase protection in 12.5 d 
whole embryos and by immunostaining in the cartilage of fe- 
tuses at 14.5 d  (data not shown).  Nine of 14 abnormal new- 
Table IlL  Morphometric Analyses of Size Differences 
between pAL21 and Wild-type  Fetuses 
% Reduction  in size for pAL21 fetuses 
15.5 d.p.c.  18.5 d.p.c. 
(5 pAL21:10 wt)  (10 pAL21:24 wt) 
Head size  5.1  10.1 (p <  0.07) 
Crown-rump  0.2  0.3 
Arm length  4.9  5.3 
Leg length  7.2  5.7 (/7 <  0.05) 
Finger length  21.5 (p <  0.05)  15.3 (p <  0.05) 
Toe length  18.3  (p <  0.05)  23.4 (p <  0.05) 
Camera incida  drawings  of  the six body  parts were made  using  a projection  at- 
tachment on a Wild-dissecting  microscope.  Measurements  of  length  were done 
by nonlinear  tracing  using a computer-assisted  digitizer  driven  by a sterometry 
program. Head size was computed  by multiplying  the maximum  length along 
the vertex-jaw  and rostral-occipital  axes. Data  were tested  for significant  differ- 
ence by non-parametric  Mann-Whitney  U test. 
~, wild-type. 
d.p.c., days  post coitum. 
The Journal of Cell Biology,  Volume 128, 1995  228 Figure 5. Histological sections of craniofacial  regions of 17.5-d (A) 
nontransgenic fetus and (B) pAL21 transgenic littermate  and (C) 
15.5-d pAL21 transgenic fetus.  Serial wax sections  were stained 
with Harris haematoxylin and oosin.  In the transgenic fetuses,  the 
midline skeletal  structures such as the nasal septum (ns), the vis- 
ceral skeleton (vs), and the skeletal elements in the floor of  the neu- 
rocranium (sk) are poorly developed,  resulting  in the medial and 
ventral displacement of the snout (sn), the nasal cavities (ca), and 
the otocyst (oc). The brain is deformed as a result of the reduction 
in the size  of the cranium,  particularly the fore-shortened skull 
floor (dashed lines). Bar,  I  mm. 
Figure 6.  Expression of Tag in pAL21 newborn mice. (A) RNase 
protection assay and (B) Western blot showing Tag expression  in 
some of the transgenic newborns.  RNA was prepared  from the 
limbs or part of the head of newborn mice and analyzed for expres- 
sion of Tag by RNase protection assays using pKC32 riboprobe 
(Fig.  1).  Protein was prepared from approximately twenty 7-#m 
cryostat sections from the same neonates (Nos.  173, 166: head and 
upper body; 165, 176, 169: head and neck; 156, 174: body) and the 
presence of Tag assayed by Western blot hybridization using ID9 
monoclonal antibody, pAL21 transgenic mice Nos.  173, 174, and 
176 were stillborn and abnormal; Nos. 165 and 169 were born alive 
with normal appearance; Nos. 156 and 166 were nontransgenic lit- 
termate.  T,  transgenic;  NT,  nontransgenic.  (A) Presence of Tag 
mRNAs are shown by the expected  sized 254 base protected frag- 
ment for Tag mRNA. Other higher molecular mass fragments rep- 
resent partially digested  products of RNase digestions.  M, DNA 
molecular mass markers, HpaII digests of pGEM2; C, tRNA con- 
trol reaction using yeast tRNA; 483/SV40, RNA from monkey kid- 
hey cell line expressing Tag; P, [32p]UTP-labeled riboprobe.  (B) A 
distinct  97-kD protein was detected by ID9 antibody in the control 
483/SV40 cells.  C, control incubation with primary Tag antibody 
omitted, showing that the bands of lower molecular mass than 97 
kD protein band represent nonspecific binding of  the secondary an- 
tibody to mouse proteins.  Tag expression  was  detected by both 
methods in Nos. 165 and 176. Mouse No. 173 expressed Tag at very 
low  levels,  with  a  signal  appearing  on  the  Western  blot  after 
prolonged exposure (/73/'*).  These findings were corroborated by 
immunohistology of sections  using ID9 to stain cryostat sections 
(data not shown).  Although transgenic  mouse 174 showed no ex- 
pression by RNAse protection or Western, a low level of Tag stain- 
ing which was patchy could be detected  by immunostaining sug- 
gesting that it could be mosaic for the transgene.  Mouse 169 was 
normal and did not express  Tag. 
Cheah et al. Chondrodysplasia in COL2A1-SV40 T Antigen Transgenic Mice  229 Figure 7. Expression of ~x  1(II) collagen and Tag in chondrogenic tissues of pAL21 transgenic mice. Sections were counterstained with either 
1% toluidine blue (D and E) or with Harris hematoxylin-eosin (F and G) after in situ hybridization. B, C, and E are pictures taken under 
dark-field illumination where silver grains appear white. D, E  and G are double exposures with a combination of bright-field with a blue 
filter and dark-field illumination under a red filter, to produce superimposed images where silver grains appear pinkish red. (A) Immuno- 
staining of Tag (1) in the rib cartilage (ca) of a  14.5-d pAL21 transgenic fetus and (2)  in the cytoplasm and nuclei of chondrocytes in 
the supra-occipital  cartilage of an abnormal pAL21 transgenic newborn which died at birth. Sections were counterstained with haematoxy- 
lin. Note tissue-specific staining of Tag in chondrocytes and not in the supporting mesenchyme (m) or perichondrium (pc). Tag mRNA 
was also detected by RNase protection in the same newborn (not shown). Levels of expression of Tag varied between individual transgenic 
founders are expected because of differences in transgene copy number and integration site. (B) Strong in situ hybridization to Col2a-I 
mRNA displayed by chondrocytes in the otic capsule (oc) and adjacent supra-occipital cartilage (sc) of the nontransgenic newborn shown 
in Fig. 3 A. (C) Diminished intensity of hybridization to Col2a-1 transcript in otic capsule (oc) and supra-occipital cartilage (sc) of a 
pAL21 transgenic littermate of B shown in Fig. 3 B. (D) Very weak hybridization  to Col2a-1 mRNA in the otic capsule (oc) of the 15.5-d 
pAL21 transgenic fetus is shown in Fig. 5 C. The otic capsule has a corrugated instead of a normal spherical shape. Low level hybridization 
is also seen in the basi-occipital cartilage (bc).  The region shown at higher magnification in E  is marked by the corners. (E) Higher 
magnification of region marked in D.  (F) The growth plate (gp) of the humerus of a nontransgenic newborn (same as C above) showing 
expression of the Co12a-1 gene in the proliferating (p) and hypertrophic chondrocytes (h). bin, bone marrow.  (G) Weaker expression of 
Co12a-1 mRNA in the growth plate (gp) of the humerus of a pAL21 transgenic littermate of B and C which had shorter limbs. Note a 
lower level of hybridization over the proliferating chondrocytes compared to the nontransgenic littermate in E  Abbreviations as for F. Bars: 
(A/) 20 ~tm; (A2) 10 gm;  (B, C, and D)  100 gin; (E-G)  50 gm. 
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cytes. Bone, mesenchyme, muscle, and skin were not stained 
which is consistent with the absence of type O collagen in 
these tissues (Fig. 7 A/and data not shown). Consistent with 
the known nuclear localization of  Tag in SV40-infected cells, 
expression was detected in the nucleus (Fig. 7 A2). Levels 
of Tag expression as assessed by the intensity of immuno- 
staining varied between transgenic mice, and there was no 
direct correlation with degree of abnormality. In 3 out of 10 
pAL21 newborns of  normal morphology, Tag staining in car- 
tilage was patchy and at very low levels indicating  these 
animals were probably mosaic for the transgene. In two of 
those animals  (such as  No.  174, Fig.  6),  Tag expression 
could not be confirmed by RNase protection assays or West- 
ern blotting. 
Tag expression was found in offspring from only two of  the 
pAL21 transgenic  founders  which  survived to adulthood: 
123 and 124, both of which produced abnormal offspring. 
The single transgenic offspring of 123 was expressing Tag in 
rib, limb, and calvaria at the time of  death. Expression of  Tag 
in line 124 was found at 14.5 d.p.c, but not in newborns. No 
expression of Tag was found at fetal or adult stages for the 
other 6 fertile transgenic lines which probably accounts for 
their normal phenotype and postnatal  survival. 
Chondrocyte  Densities Are Reduced in pAL21 
Transgenic Mice 
A significant reduction (20--30%) of the cell population was 
found for the proliferative and prehypertrophic chondrocytes 
in different cartilaginous organs, including otic capsule, na- 
sal septum,  base of skull, vertebrae,  occipital bone, digit, 
and humerus of the transgenic pAL21 fetuses, particularly 
at late gestation (Table IV). The decreased number of chon- 
drocytes cannot be attributed  to an increase in matrix be- 
cause to the contrary, amounts were reduced. In situ hybrid- 
ization of  tissue sections of  pAL21 fetuses at 15.5, 17.5, 18.5 d 
and in newborns  using a  Col2a-1 gene probe  showed re- 
duced levels of hybridization (Fig. 7, B-G). The density of 
silver grains over the five cartilaginous tissues from a range 
of pAL21 transgenic and nontransgenic fetuses was exam- 
ined and compared in experiments using the same riboprobe 
and identical  exposure  times.  Levels  of hybridization  in 
chondrogenic tissues were very high for nontransgenic fe- 
tuses. Low levels of hybridization were found in '~20%  of 
the pAL21 fetuses and were associated with severe abnor- 
malities in cartilaginous structures  (Fig. 7, D and E). The 
remaining pAL21 fetuses displayed moderate to strong levels 
of hybridization  (Fig.  7  C).  Transgenic  fetuses  showing 
strong levels of  hybridization were morphologically normal. 
In the growth plate shown in Fig. 7 G, fewer cells were posi- 
tive for od(X) collagen, a marker for hypertrophic chondro- 
cytes (data not shown). 
It was not possible in every case to determine if the lower 
levels of hybridization seen reflected a decrease in chondro- 
cyte numbers alone or included reduced levels of Col2a-1 
mRNAs on a per cell basis. However, the lower level or ab- 
sence of hybridization in hypertrophic chondrocytes seen in 
several pAL21 animals compared to wild-type (Fig. 7, F and 
G) indicates that cellular  levels of Col2a-1 mRNAs were 
reduced. In two fetuses hybridization was high in the mor- 
phologically normal vertebrae but was low in the under de- 
veloped nasal septum. In two neonates with craniofacial ab- 
normalities, reduced hybridization signal was found in the 
otic capsule and growth plate of the humerus (Fig. 7, D and 
G) but not in proliferating chondrocytes of vertebrae. Low- 
ered hybridization levels found only in abnormal cartilage 
but not in morphologically normal cartilaginous structures 
in a single animal suggests a direct association between carti- 
lage abnormality and a reduction in cell density and/or type 
II collagen gene expression. 
pAL21 Chimeras Show Skeletal Malformation and 
Abnormal Chondrocyte Differentiation 
Due to the dominant perinatal lethal effect of the Tag trans- 
gene in pAL21 mice, and because each individual transgenic 
newborn  or embryo is the product  of unique integrations 
Table IV.  Comparison of Chondrocyte Densities in Cartilaginous Tissues of pAL21 and Wild-type Fetuses 
Chondrocyte density (No./mm  2) 
Wild type, n  =  5  pAl-,2l (% reduction in density) n  =  5 
Cartilaginous 
structures  15.5 d.p.c.  17.5 d.p.c.  18.5 d.p.c.  15.5 d.p.c.  17.5 d.p.c.  18.5 d.p.c. 
Otic capsule  9.85  +  0.70  8.03  ±  0.38  9.29  +  0.80  6.88  +  0.89  (30.1)  5.65  +  0.45* (29.6)  6.10  +  0.91" (34.3) 
Base of skull  8.20  +  0.45  8.61  ±  0.36  ND  5.45  ±  0.21, (33.5)  6.88  +  0.27* (20.1)  ND 
Occipital bone  9.75  4- 0.71  7.90  +  0.27  ND  7.06  4- 0.54* (27.6)  5.25  ±  0.38t (33.5)  ND 
Vertebrae  9.80  ±  0.68  7.91  ±  0.77  ND  7.51  ±  0.37* (23.4)  5.48  4- 0.20* (30.7)  ND 
Digit  ND  ND  8.72  4-  1.12  ND  ND  6.99  ±  0.79H  (19.8) 
Forelimb  ND  ND  6.74  ±  0.70  ND  ND  5.11  +  0.621 (24.2) 
humerus 
Nasal septum  9.35  ±  0.41  8.51  ±  0.59  8.34  4- 0.37  6.32  ±  0.44~ (32.4)  6.59  +  0.43* (22.6)  6.23  +  0.51, (21.0) 
Chondrocyte density was estimated  on stained sections of pAI.,21 transgenic and wild-type 15.5-,  17.5-,  and 18.5-d fetuses.  The total number of chondrocytes 
(proliferating  and prehypertrophic) was scored in a defined area of the cartilage.  Scoring was done at 20 magnification and three separate counts were obtained 
from each section. 
*p <  0.05. 
t p  < 0.01. 
§ p  <  0.001. 
II p  <  0.0556. 
I p  <  0.0079:  significant difference in chondrocyte density between pAL21  fetuses and nontransgenic  littermates. 
ND, not determined. 
d.p.c.,  days post coitum. 
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analysis of the effect of COL2A1 targeted Tag expression on 
chondrocyte differentiation and on postnatal skeletal devel- 
opment was not possible. To overcome this difficulty, em- 
bryonic stem  (ES) cells which carry integrated copies of 
pAL21 were used to produce mouse chimeras. Four of these 
chimeras have survived to neonatal stages but were typically 
smaller than normal non-chimeric mice and displayed severe 
kyphosis (Fig. 8 A) and retarded ossification of the skeleton. 
Severity of phenotype correlated well  with the degree of 
chimerism (data not shown). Analyses of two such chimeric 
neonates, revealed the presence of islands of cells within ar- 
ticular cartilage with densely packed cells (Fig. 8) and re- 
duced  intercellular toluidine  blue  staining  indicating  re- 
duced amounts of matrix (not shown).  Similar islands  of 
cells were found in the epiphyseal growth plate of lone bones 
but they were not organized into columns of proliferating 
chondrocytes. These islands of cells could also be found in 
a chimeric fetus at 15.5 d (Fig. 8 K), which also showed dis- 
organization of other cartilages  such  as  otic capsule and 
carpals of the foot plate (data not shown). Tissue specific ex- 
pression of Tag in the chimeric neonates could be demon- 
strated by RNA and protein analyses. In situ hybridization 
showed that the cells within these  islands  expressed Tag 
mRNAs, which were absent in normally organized chondro- 
cytes, perichondrium, skin, and muscle (Fig. 8 B). Expres- 
sion of Tag in cartilaginous tissues was also confirmed by 
Western analyses of protein extracted from chimeric tissues 
(data not shown). 
Chondrogenesis is a  multistep process whereby mesen- 
chymal cells differentiate into chondrocytes which mature, 
proliferate, and finally become hypertrophic. These stages of 
differentiation are marked by the expression of characteristic 
mRNAs.  Type  II  procollagen  mRNAs  are  alternatively 
spliced to give a type IIA form which contains an extra exon 
encoding a cysteine-rich domain or type lib form without 
this exon (Ryan and Sandell, 1990). The HA form is prefer- 
entially  expressed  by  prechondrocytes  and  proliferating 
chondrocytes but not by mature or hypertrophic chondro- 
cytes (Sandell et al.,  1991; Ng et al.,  1993). Differentiated 
chondrocytes (mature, proliferating, and hypertrophic) ex- 
press the type fib form. There are two alternative transcripts 
for the od(IX) collagen gene, one encoding a long form tx 
chain with a 266-amino acid globular domain, and the other, 
a short form tx chain without. In chick and mouse, maturing 
and  proliferating chondrocytes express long  form txl(IX) 
collagen mRNA whereas the short form is restricted to pre- 
chondrocytes and non-chondrogenic tissues (Swiderski and 
Solursh, 1992a,b; Liu et al., 1993; Ng, L. J., P. P. L. Tam, 
and K.  S.  E.  Cheah manuscript in preparation).  Type X 
collagen is  only expressed by hypertrophic chondrocytes 
(Schmid and Linsenmayer, 1987). Chondrocytes do not ex- 
press type I collagen (Cheah et al.,  1991) and its synthesis 
is a sign of dedifferentiation (Benya and Brown,  1986). 
The identity of the cells within the islands and their state 
of differentiation was assessed by the expression of genes 
which are characteristic markers for chondrocytes. These 
cells hybridized with the exon 1 probe of Col2a-1 gene albeit 
at a lower level compared to their surrounding normal coun- 
terparts (Fig. 8 C). The absence of hybridization to the type 
llA-specific probe shows the islands of cells were expressing 
type liB procollagen (Fig. 8, C1 and G). These cells also ex- 
pressed mRNAs for o~2(XI)  collagen, the long form of  od(IX) 
collagen, and aggrecan (Fig. 8, D-F). Levels of expression 
of other cartilage characteristic mRNAs,  such as aggrecan 
and o~2(XI) collagen mRNAs were not affected in the disor- 
ganized chondrocytes (Fig. 8, D-F). There was no expres- 
sion of mRNAs for od(I) collagen, the short form of od(IX) 
collagen, and type X collagen (Fig.  8, H-J). 
Discussion 
The skeletal abnormalities displayed by pAL21 mice resem- 
ble  the  disproportionate dwarfism  seen  in  human  chon- 
drodysplasia and in those transgenic mice carrying mutant 
Col2a-1  alleles (Metsiranta et al.,  1992;  Garofalo et al., 
Figure 8. Expression of Tag and gene markers on chondrocyte differentiation in articular cartilage and growth plate of pAL21 chimeric 
mice. In situ hybridization study of genes expressed in the epiphyses of pAL21 chimeric mice. Sections (B-J) were counterstained with 
Harris haematoxylin-eosin after in situ hybridization. B, C2, G, I, and J are pictures taken under dark-field ilJumination. D-F and H 
are double exposures as described for Fig. 7. C1 is a bright-field picture of C2. Sections K1 and K2 were counterstained 1% toluidine 
blue. The greenish color seen in the durk-field pictures G and I is due to histological staining of the emulsion. (A) An 8-d-old chimeric 
pup (C21.6) produced using ES cells Carrying four copies of pAL21 showing foreshortened snout, stumpy limbs, and a hunched back (ar- 
rows) caused by severe kyphosis. Degree of chimerism as determined by estimation of pAL21 copy number in seven different tissues from 
C21.6 with reference to an endogenous gene (type X collagen) varied from 18-59% (data not shown). (B) Dark-field picture of in situ 
hybridization showing signal for Tag mRNA in the islands (dashed outlines) of disorganized chondrocytes in the limb articular cartilage 
and growth plate of C21.6. Hybridization signal was at background levels in normal proliferating (p) and hypertrophic (h) chondrocytes, 
pericbondrium (pc), muscle (mu), and bone marrow ceils (bra). (C) In situ hybridization showing strong signal for txl0D collagen mRNA 
in normal proliferating chondrocytes (p) and reduced levels in the islands (dashed outlines ) of  disorientated chondrocytes in the limb growth 
cartilage of C21.6. Transcripts correspond to the liB form of txl(ID collagen mRNA because HA is not expressed (see G). Hybridization 
signal was absent in bone marrow cells (bin). (D-F) In situ hybridization showing strong signals for mRNAs for long form ~I(IX) (D), 
collagen c~2(XI) collagen (E), aggrecan (F) in the islands of cells (dashed outlines) and the surrounding normally organiTed  chondrocytes 
(representative regions marked by *). Abbreviations as for R  (G-J) In situ hybridization showing absence of expression of transcripts 
for the type HA form of the ,10I) collagen gene (G), t~l(I) collagen (H), short form o~l(IX) collagen (I), and type X collagen (J) in the 
islands of cells (dashed outlines). Silver grains over the islands of cells were at background level, comparable to the surrounding normal 
chondrocytes. Note expression of type X collagen mRNA by hypertrophic chondrocytes (h) surrouadin~ the island of ceils. Type HA and 
short form txl(IX) mRNAs were restricted to prechondrocytes (arrows). Type I collagen mRNAs were restricted to the perichondrium 
(not shown) and trabeculae. G, I, and J, dark-field picture; H, double exposure. Abbreviations as for R  (K) Sections of the long bone 
cartilage of 15.5 d.p.c, non-chimeric (K/) and chimeric (K2) fetal littermates. Note presence of  islands of  cells interrupting the hypertrophic 
zone in K2 (black arrows).  Abbreviations as for B. Bars: (A) 1 cm; (B, D, G, and K) 100 ~m; (C-F, H-J) 50/zm. 
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1990; Horton and Hecht, 1993) where the mutant phenotype 
can be attributed to the presence of aberrant type II collagen 
molecules in the matrix. But the pAL21  phenotype is not 
caused by a mutation in the Col2a-1  gene. Several lines of 
evidence show that the skeletal abnormalities seen in the 
COL2A1-Tag transgenic mice could be specifically attributed 
to the transgene.  First, the common skeletal abnormality 
found in large numbers of different pAL21 mice excludes the 
possibility  of an  integration  site-specific  effect.  Second, 
pAA2 transgenic mice showed a lower frequency of unrelated 
abnormality suggesting that the  skeletal abnormalities in 
~AL21 mice were not due to a competition for Co12a-1 tran- 
scription factors caused by the integration of the COL2A1 
sequences. 
Third, the detection of Tag in some 12.5-d embryos in ad- 
vance of chondrogenesis,  the ability of the COL2A1  se- 
quences in pAL21  and pAA2  to direct expression of the 
transgenes to the major sites of expression of Col2a-1,  and 
the correlation between the type of affected tissues in pAL21 
transgenic fetuses and the known sites of expression of the 
Col2a-1 gene during embryogenesis (Table 1II and [Cheah et 
al., 1991]) implicate Tag as the cause of the skeletal malfor- 
mations. Levels of  expression of  Tag varied in different  trans- 
genics since each of these differ in copy number and integra- 
tion site. Tag may also be inappropriately expressed in some 
cases because of the influence of genomic sequences at the 
site of transgene integration. This is normal for transgenic 
experiments. It is likely that the presence of Tag precedes the 
appearance of abnormality and although Tag could not be 
demonstrated in all abnormal pAL21  mice when they were 
assayed, previous Tag expression cannot be excluded. Tag 
found in some mice with no clear abnormality could repre- 
sent a combination of inappropriate timing, low level of ex- 
pression of  the transgene and/or mosaic expression since Tag 
levels were very low and immunostaining was patchy. 
Several  observations suggest that the chondrodysplastic 
phenotype in pAL21 transgenic mice may be caused by an 
impaired or retarded ability of chondrocytes to differentiate 
fully. First,  there was a  correlation between reduction in 
chondrocyte densities and abnormalities in cartilaginous tis- 
sues of some pAL21 fetuses (Figs. 5 and 7). Second, in five 
abnormal pAL21  18.5-d  fetuses showing disproportionate 
limb reduction, there was reduced chondrocyte density in the 
growth plate of the humerus (Table IV). Third, in some ab- 
normal pAL21 transgenic neonates there was reduced hyper- 
trophy of chondroeytes and a paucity of matrix (Figs. 4 and 
7). Endochondral ossification was also less advanced com- 
pared to nontransgenic littermates (Fig. 5).  These pheno- 
typic deviations are consistent with an immature state of 
differentiation  (Horton,  1993).  Fourth,  islands  of  cells 
which expressed Tag and were improperly organized were 
found in the articular and growth plate cartilage of 15.5-d 
chimeric fetuses and in chondrodysplastic pAL21  chimeric 
neonates. Because Tag expression could be detected in some 
transgenic embryos as early as at 12.5 d and reduced chon- 
drocyte densities were found at 15.5 d, an effect of Tag on 
proliferation cannot be excluded.  However such an effect 
would have to be tested for using specific assays such as 
thymidine uptake studies. 
In the chimeras, the expression of cartilage characteristic 
genes (type IIB,  long form od(IX),  a2(XI)  collagens and 
aggrecan) and the absence of type I collagen mRNA by the 
disorganized cells within the islands, indicate that they were 
chondrocytes. The presence of disorganized chondrocytes at 
fetal as well as neonatal stages and the absence of expression 
of type X, type HA, and short form type IX collagens by 
these cells (Fig. 8), suggest that in the chimeras, pAL21- 
derived ceils can undergo chondrogenesis but there is re- 
tardation or  failure of progression to  the  final stages  of 
proliferation, terminal differentiation, and hypertrophy. The 
absence of type X collagen expression in the islands of cells 
in  the  chimeras  also  suggest  that  the  chondrodysplastic 
phenotype in Tag mice is not simply a consequence of low- 
ered levels of type II collagen expression. Because the ES- 
derived chondrocytes fail to participate properly with the 
host cells in columnar organization, this disrupts the growth 
plate. The reduction in proliferating and hypertrophic chon- 
drocytes found for pAL21 transgenic mice correlates well 
with these findings and suggests that retarded differentiation 
is the more likely. In transgenics there was no disorganiza- 
tion probably because all the cells were behaving similarly. 
Instead poorer or retarded differentiation and/or prolifera- 
tion would result in fewer numbers of chondrocytes and a 
reduction of cartilage size. This defect in differentiation was 
probably not restricted to the growth plate since other car- 
tilages, such as nasal septum, base of skull, vertebrae, and 
otic  capsule  were  malformed  in  some  transgenics  and 
chimeras. 
It is worth noting that disorganized and densely packed im- 
mature chondrocytes have been observed in some examples 
of human chondrodysplasias where the molecular basis of 
the disease is unknown (Horton and Hecht, 1993). An exam- 
ple is thanatophoric dysplasia, which is characterized by a 
lack of organized chondrocytes and a reduction in numbers 
of proliferative and hypertrophic chondrocytes suggesting a 
defect in differentiation/proliferation. Reduced chondrocyte 
proliferation has recently been reported in a short rib syn- 
drome type Beemer patient (Brenner et al., 1993). In addi- 
tion lethal skeletal dysplasia in mice lacking parathyroid hor- 
mone-related peptide has been shown to be associated with 
premature  maturation  of  chondrocytes  (Karaplis  et  al., 
1994). 
Cultured SV40 transformed chondrocytes dedifferentiate 
and downregulate type II collagen gene expression (Thenet 
et al.,  1992),  although an exception has been reported re- 
cently (Mallein-Gerin and Olsen,  1993).  Those  cultured 
SV40  transformed mouse chondrocytes which maintained 
phenotype were, however,  unable to undergo hypertrophy 
(Mallein-Gerin and Olsen, 1993). It is of note that there was 
a reduction in the number of hypertrophic chondrocytes in 
some of the pAL21 transgenic mice and an absence of type 
X  collagen expression in pAL21-ES  cell-derived disorga- 
nized chondrocytes in the chimeras.  Levels of expression 
of cd0I) collagen mRNAs were reduced in abnormal trans- 
genies and for those disorganized groups of chondrocytes 
seen in the chimeras. Restriction of these changes to the is- 
lands of cells suggest the effect of Tag is cell autonomous. 
One way Tag is thought to cause changes in transcriptional 
activity is by mediating the modification or induction of cel- 
lular DNA-binding factors (Stahl and Knippers, 1987; Gallo 
et al., 1990).  An examination of the 5' flanking region and 
first intron of the human and mouse od(II) collagen genes 
(Vikkula et al.,  1992)  reveals  the presence of several se- 
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has also been shown to alter the cell-cycle duration of ex- 
ponentiallly  growing cells (Sladek and Jacobberger, 1992). 
Therefore,  Tag could have interfered  with the expression of 
the Col2a4 gene and the terminal differentiation of chondro- 
cytes in the pAL21 transgenic  mice. 
To determine the precise cause of the chondrodysplasia 
in pAL21 mice, it would be important to distinguish  if ab- 
normal chondrocyte differentiation  was the primary conse- 
quence of Tag expression or was secondary, as a response to 
Tag-induced downregulation  of type H collagen expression. 
A developmental  study of Tag expression and the onset of  ab- 
normal chondrocyte differentiation  in the chimeras as well 
as identification  of the gene targets for Tag action,  will help 
address this question.  Since levels of type II collagen expres- 
sion were reduced not ablated, an additional approach could 
be to determine the consequence of introducing pAL21 into 
the germline of phenotypically normal transgenic mice which 
overexpress type H collagen such as those described by Garo- 
falo et al. (1993). One could also determine if there were ab- 
normalities  in chondrocyte differentiation  where Col2ad is 
downregulated,  such as may be found for mice heterozygous 
for a null mutation in the gene created by gene targeting. 
The lack of  hyperplasia or tumor formation in pAL21 mice 
is intriguing.  In the majority of Tag transgenesis  studies, the 
gene has been controlled by viral promoters, or regulatory 
elements of genes which are expressed either widely or in 
specific  tissues  with expression  extending  into adulthood. 
Targeted expression of Tag or integration of the early region 
of SV40 virus in mice usually promotes tumorigenesis  in 
specific  tissues  after  birth  (Hanahan,  1988;  Adams  and 
Cory, 1991). The phenotypic consequence of tissue specific 
and restricted expression of Tag during embryogenesis is 
poorly understood.  We have found previously that expres- 
sion of the al0I) collagen gene declines after birth with little 
expression once growth ceases (Lovell-Badge et al., 1987). 
Perhaps  this  additional  imposition  of a  developmentally 
regulated  schedule  which restricts  Tag expression  to em- 
bryonic and growth phases of development is the reason for 
the absence of  tumors in pAL21 mice. Tumor promotion may 
require sustained postnatal expression of Tag to enable syn- 
ergistic  factors to act.  Whether  some cell types may be 
refractory to Tag action with respect to tumor promotion is 
controversial.  In a recent report, SV40 transformed murine 
chondrocytes which  retain  their  differentiated  phenotype 
failed to produce tumors in mice, suggesting that in chondro- 
cytes, Tag expression alone is not sufficient for tumor promo- 
tion (Mallein-Gerin  and Olsen,  1993). Targeted expression 
of Tag via the opsin gene promoter to the retina of transgenic 
mice results  in selective proliferation  followed by the de- 
generation  of rod  photoreceptor  cells  (AI-Ubaidi  et  al., 
1992). Transgenic mice expressing Tag under the control of 
the myelin basic protein promoter displayed hypomyelina- 
tion and neurological  disturbances such as convulsions  and 
hindlimb  ataxia (Jensen et al.,  1993). These findings indi- 
cate that hyperplasia or a predisposition to tumor formation, 
although common, is not the only consequence of expression 
of Tag in transgenic  mice. 
Despite the apparent similarity of the phenotype displayed 
by pAL21 transgenic mice and other mice expressing mutant 
Col2a-1 alleles (Mets~anta et al.,  1992;  Garofalo  et al., 
1991; Vandenberg  et al.,  1991), the  chondrodysplasia of 
pAL21 mice has not been caused by a structural  alteration 
of a matrix molecule but may be due to a poorer differentia- 
tion of chondrocytes.  The recent reports of abnormalities  in 
chondrocyte proliferation  and  maturation  in  examples  of 
skeletal dysplasia in human and mouse (Brenner et al., 1993; 
Karaplis  et al.,  1994) support the possibility that multiple 
causative  factors apart  from impaired integrity  of matrix 
components may also result in chondrodysplasia.  The COL- 
2A1-Tag transgene provides a tool for investigating this possi- 
bility and for analyzing  the complex relationships  between 
quality of cartilage matrix, chondrocyte differentiation,  and 
phenotype during  skeletogenesis and  the pathogenesis  of 
chondrodysplasia.  The use of ES cells and chimeras also 
provides  a useful approach for overcoming  the problem of 
perinatal  lethality when transgenes produce dominant muta- 
tions in matrix genes. 
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